SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001193125-22-263393
Filing Date
2022-10-17
Accepted
2022-10-17 08:32:00
Documents
1
Effectiveness Date
2022-10-17

Document Format Files

Seq Description Document Type Size
1 15-12G d403698d1512g.htm 15-12G 10079
  Complete submission text file 0001193125-22-263393.txt   11082
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-37539 | Film No.: 221312610
SIC: 2834 Pharmaceutical Preparations